Alto Neuroscience, Inc. (ANRO)
NYSE: ANRO · Real-Time Price · USD
17.80
-0.14 (-0.78%)
At close: Dec 31, 2025, 4:00 PM EST
17.72
-0.08 (-0.45%)
After-hours: Dec 31, 2025, 7:00 PM EST
Alto Neuroscience Market Cap
Alto Neuroscience has a market cap or net worth of $552.98 million as of December 31, 2025. Its market cap has increased by 435.34% in one year.
Market Cap
552.98M
Enterprise Value
440.56M
1-Year Change
435.34%
Ranking
Category
Stock Price
$17.80
Market Cap Chart
Since February 2, 2024, Alto Neuroscience's market cap has increased from $528.69M to $552.98M, an increase of 4.59%. That is a compound annual growth rate of 2.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 552.98M | 384.71% |
| Dec 31, 2024 | 114.08M | -78.42% |
| Feb 2, 2024 | 528.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 965.87B |
| Johnson & Johnson | 500.07B |
| AbbVie | 407.98B |
| UnitedHealth Group | 297.97B |
| AstraZeneca | 287.56B |
| Novartis AG | 266.91B |
| Merck & Co. | 264.63B |
| Novo Nordisk | 229.27B |